Thu, September 1, 2022

Neena Bitritto-Garg Maintained (ATAI) at Strong Buy with Decreased Target to $20 on, Sep 1st, 2022

Neena Bitritto-Garg of Citigroup, Maintained "Atai Life Sciences N.V." (ATAI) at Strong Buy with Decreased Target from $22 to $20 on, Sep 1st, 2022.

Neena, nor any peers, have made any analyst calls on ATAI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30